Envista Holdings (NVST) Other Non-Current Liabilities (2018 - 2026)
Envista Holdings (NVST) posted quarterly Other Non-Current Liabilities of $161.4 million for Q2 2026, up 9.42% year-over-year from $147.5 million in Q2 2025, and little changed quarter-over-quarter from $161.4 million in Q4 2025.
Envista Holdings (NVST) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $161.4 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities rose 9.42% year-over-year to $161.4 million; the TTM figure through Apr 2026 stood at $161.4 million (up 9.42% YoY), while the FY2025 annual figure was $161.4 million, up 15.45% from the prior year.
- Other Non-Current Liabilities for Q2 2026 stood at $161.4 million, roughly flat from $161.4 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $288.2 million in Q2 2022, with the low at $136.7 million in Q1 2024.
- The 5-year median for Other Non-Current Liabilities is $151.3 million (2022), against an average of $167.3 million.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities slumped 51.53% in 2022, then advanced 16.2% in 2025.
- Envista Holdings' Other Non-Current Liabilities stood at $151.3 million in 2022, then slipped by 5.88% to $142.4 million in 2023, then slipped by 1.83% to $139.8 million in 2024, then rose by 15.45% to $161.4 million in 2025, then changed by 0.0% to $161.4 million in 2026.
- Business Quant data shows NVST's Other Non-Current Liabilities at $161.4 million in Q2 2026, $161.4 million in Q4 2025, and $169.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Envista Holdings | 4.40 Bn | 3.27 Bn | 407.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 164.00 Mn |
| Apr 3, 2026 | 161.40 Mn |
| Dec 31, 2025 | 161.40 Mn |
| Sep 26, 2025 | 169.70 Mn |
| Jun 27, 2025 | 171.40 Mn |
| Mar 28, 2025 | 147.50 Mn |
| Dec 31, 2024 | 139.80 Mn |
| Sep 27, 2024 | 149.70 Mn |
| Jun 28, 2024 | 147.50 Mn |
| Mar 29, 2024 | 136.70 Mn |
| Dec 31, 2023 | 142.40 Mn |
| Sep 29, 2023 | 150.50 Mn |
| Jun 30, 2023 | 153.00 Mn |
| Mar 31, 2023 | 151.30 Mn |
| Dec 31, 2022 | 151.30 Mn |
| Sep 30, 2022 | 220.70 Mn |
| Jul 1, 2022 | 201.30 Mn |
| Apr 1, 2022 | 288.20 Mn |
| Dec 31, 2021 | 304.20 Mn |
| Oct 1, 2021 | 318.20 Mn |